Renaissance Technologies (RenTech)'s NXTC Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 171,202 shares of NextCure, Inc. (NXTC) worth $273,923, representing 0.00% of the portfolio. First purchased in 2020-Q2, this long-term strategic position has been held for 23 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in NXTC, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 110,668 shares. Largest reduction occurred in Q4 2021, reducing 22,042 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s NextCure (NXTC) Holding Value Over Time
Track share changes against reported price movement
Quarterly NextCure (NXTC) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +110,668 | Add 182.82% | 171,202 | $1.60 |
| Q1 2026 | +26,900 | Add 79.98% | 60,534 | $10.68 |
| Q4 2025 | +5,300 | Add 18.71% | 33,634 | $14.19 |
| Q3 2025 | -13,411 | Reduce 32.13% | 28,334 | $5.86 |
| Q2 2025 | +1,748 | Add 4.37% | 41,745 | $5.52 |
| Q1 2025 | -3,278 | Reduce 7.57% | 39,997 | $5.76 |
| Q4 2024 | +9,442 | Add 27.91% | 43,275 | $9.25 |
| Q3 2024 | -4,679 | Reduce 12.15% | 33,833 | $16.44 |
| Q2 2024 | +5,145 | Add 15.42% | 38,512 | $19.08 |
| Q1 2024 | +8,924 | Add 36.51% | 33,367 | $26.76 |
| Q4 2023 | +3,593 | Add 17.23% | 24,443 | $13.66 |
| Q3 2023 | +250 | Add 1.21% | 20,850 | $15.49 |
| Q2 2023 | +225 | Add 1.10% | 20,600 | $0.02 |
| Q1 2023 | -13,507 | Reduce 39.86% | 20,375 | $0.02 |
| Q4 2022 | +14,715 | Add 76.77% | 33,882 | $0.02 |
| Q3 2022 | -5,145 | Reduce 21.16% | 19,167 | $33.03 |
| Q2 2022 | +11,912 | Add 96.06% | 24,312 | $56.39 |
| Q1 2022 | +3,267 | Add 35.77% | 12,400 | $58.31 |
| Q4 2021 | -22,042 | Reduce 70.70% | 9,133 | $72.05 |
| Q3 2021 | +14,483 | Add 86.77% | 31,175 | $80.87 |
| Q2 2021 | +16,692 | New Buy | 16,692 | $96.33 |
| Q3 2020 | -5,342 | Sold Out | 0 | $0.00 |
| Q2 2020 | +5,342 | New Buy | 5,342 | $257.21 |
Renaissance Technologies (RenTech)'s NextCure Investment FAQs
Renaissance Technologies (RenTech) first purchased NextCure, Inc. (NXTC) in Q2 2020, acquiring 5,342 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held NextCure, Inc. (NXTC) for 23 quarters since Q2 2020.
Renaissance Technologies (RenTech)'s largest addition to NextCure, Inc. (NXTC) was in Q2 2026, adding 171,202 shares worth $273,923.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 171,202 shares of NextCure, Inc. (NXTC), valued at approximately $273,923.
As of the Q2 2026 filing, NextCure, Inc. (NXTC) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in NextCure, Inc. (NXTC) was 171,202 shares, as reported at the end of Q2 2026.